Melanoma

From the Field
Anticipated Cost Savings with Alternate Dosing Schema of Nivolumab/Ipilimumab for the Treatment of Metastatic Melanoma
08/20/2021
Allison Kupsh, PharmD, and colleagues found that the anticipated cost of NIVO3+IPI1 for the treatment of metastatic melanoma may be lower compared when compared with NIVO1+IPI3, amounting to over $1,000,000 in total savings.
Allison Kupsh, PharmD, and colleagues found that the anticipated cost of NIVO3+IPI1 for the treatment of metastatic melanoma may be lower compared when compared with NIVO1+IPI3, amounting to over $1,000,000 in total savings.
Allison Kupsh, PharmD, and...
08/20/2021
Journal of Clinical Pathways
News
Cutaneous AEs Mild, Manageable With Immune Checkpoint Inhibitors for Melanoma
07/16/2020
Cutaneous adverse events (AEs) from anti-CTLA4 and anti-PD1 combination therapy for metastatic melanoma are mostly mild and can be managed using topical steroids and/or oral histamines, according to a study published...
Cutaneous adverse events (AEs) from anti-CTLA4 and anti-PD1 combination therapy for metastatic melanoma are mostly mild and can be managed using topical steroids and/or oral histamines, according to a study published...
...
07/16/2020
Journal of Clinical Pathways
Online Exclusive
When A Suspected Granuloma Turns Out To Be Acral Lentiginous Melanoma
11/01/2019
Acral lentiginous melanoma can be particularly difficult to diagnose in the nail, as it classically presents as a black-brown longitudinal band typical of longitudinal melanonychia. However, these authors note with this case study that...
Acral lentiginous melanoma can be particularly difficult to diagnose in the nail, as it classically presents as a black-brown longitudinal band typical of longitudinal melanonychia. However, these authors note with this case study that...
Acral lentiginous melanoma can...
11/01/2019
Podiatry Today
Case Report
CASE REPORT Nodular Melanoma in an African American Female
10/04/2019
CASE REPORT Nodular Melanoma in an African American Female Vincent Brown, MD,a Tom Reisler, BSc(Hons), MB ChB, MRCS(Ed),b and Jake Laks, MDa aDepartment of Surgery, The Brody School of Medicine, East Carolina University,...
CASE REPORT Nodular Melanoma in an African American Female Vincent Brown, MD,a Tom Reisler, BSc(Hons), MB ChB, MRCS(Ed),b and Jake Laks, MDa aDepartment of Surgery, The Brody School of Medicine, East Carolina University,...
CASE REPORT Nodular...
10/04/2019
ePlasty
Case Report and Brief Review
Misdiagnosed Malignant Tumor on an Ischemic Limb
02/06/2019
The authors present the case of a 68-year old man who smokes with a history of hypertension, diabetes, and dyslipidemia, who was referred to the vascular clinic with complaints of intermittent claudication and a developing ulcer on his heel.
The authors present the case of a 68-year old man who smokes with a history of hypertension, diabetes, and dyslipidemia, who was referred to the vascular clinic with complaints of intermittent claudication and a developing ulcer on his heel.
The authors present the case of...
02/06/2019
Wounds
News
Combining Y90 Transarterial Radioembolization With Immunotherapy is Safe
09/09/2018
Yttrium-90 (90Y) transarterial radioembolization (TARE) around immunotherapy is safe and effective and the combined treatment may improve hepatic progression-free survival (hPFS) and overall survival (OS) in patients with hepatic metastases...
Yttrium-90 (90Y) transarterial radioembolization (TARE) around immunotherapy is safe and effective and the combined treatment may improve hepatic progression-free survival (hPFS) and overall survival (OS) in patients with hepatic metastases...
Yttrium-90 (90Y) transarterial...
09/09/2018
IO Learning
Case Report and Brief Review
Synergism of Therapies After Postoperative Autograft Failure in a Patient With Melanoma of the Foot Misdiagnosed as a Pressure Ulcer
04/12/2018
04/12/2018
Wounds
Quiz
Best Targeted Therapy for Melanoma
11/10/2016
JCP Editors
A study published in JAMA Oncology recently showed that treatment with which of the following drug types was just as effective as BRAF- and MEK-targeted therapies for melanoma and also limited the risk of...
A study published in JAMA Oncology recently showed that treatment with which of the following drug types was just as effective as BRAF- and MEK-targeted therapies for melanoma and also limited the risk of...
A...
11/10/2016
Journal of Clinical Pathways
Research in Review
Surveillance Superior to Standard Care for Melanoma
11/01/2016
JCP Editors
Specialized surveillance may be more cost effective and lead to fewer invasive procedures compared with standard care for patients with a high risk of melanoma, according to a study published in the Journal of...
Specialized surveillance may be more cost effective and lead to fewer invasive procedures compared with standard care for patients with a high risk of melanoma, according to a study published in the Journal of...
...
11/01/2016
Journal of Clinical Pathways
Research in Review
Ipilimumab Combination Significantly Improves Melanoma Outcomes
07/27/2016
JCP Editors
Ipilimumab (Yervoy; Bristol-Myers Squibb) combined with local peripheral treatments such as radiotherapy or electrochemotherapy may significantly prolong survival in patients with melanoma compared with...
Ipilimumab (Yervoy; Bristol-Myers Squibb) combined with local peripheral treatments such as radiotherapy or electrochemotherapy may significantly prolong survival in patients with melanoma compared with...
...
07/27/2016
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use